Risk Assessment and Virological Monitoring Following an Accidental Exposure to Concentrated Sabin Poliovirus Type 3 in France, November 2018

The safe and secure containment of infectious poliovirus (PV) in facilities where live PV are handled is the condition to achieve and maintain poliomyelitis eradication. Despite precautions to minimize the risk of release of PV from such facilities to the environment, breaches of containment have al...

Full description

Bibliographic Details
Main Authors: Marion Jeannoël, Denise Antona, Clément Lazarus, Bruno Lina, Isabelle Schuffenecker
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/8/2/331
id doaj-3bb83dfc819948d98fcd2394dd075f34
record_format Article
spelling doaj-3bb83dfc819948d98fcd2394dd075f342020-11-25T03:44:44ZengMDPI AGVaccines2076-393X2020-06-01833133110.3390/vaccines8020331Risk Assessment and Virological Monitoring Following an Accidental Exposure to Concentrated Sabin Poliovirus Type 3 in France, November 2018Marion Jeannoël0Denise Antona1Clément Lazarus2Bruno Lina3Isabelle Schuffenecker4Centre National de Référence des Entérovirus et Parechovirus, WHO National Poliovirus Laboratory, Institut des Agents Infectieux, Groupement Hospitalier Nord, Hospices Civils de Lyon, 69317 Lyon, FranceSanté Publique France, 94410 Saint Maurice, FrancePublic Health Emergency Operations Centre, Division of Surveillance and Health Security, General Directorate for Health, Ministry of Solidarity and Health, 75350 Paris, FranceCentre National de Référence des Entérovirus et Parechovirus, WHO National Poliovirus Laboratory, Institut des Agents Infectieux, Groupement Hospitalier Nord, Hospices Civils de Lyon, 69317 Lyon, FranceCentre National de Référence des Entérovirus et Parechovirus, WHO National Poliovirus Laboratory, Institut des Agents Infectieux, Groupement Hospitalier Nord, Hospices Civils de Lyon, 69317 Lyon, FranceThe safe and secure containment of infectious poliovirus (PV) in facilities where live PV are handled is the condition to achieve and maintain poliomyelitis eradication. Despite precautions to minimize the risk of release of PV from such facilities to the environment, breaches of containment have already been documented. Here, we report the management of an incident that occurred on 30 November 2018 in a French vaccine manufacturing plant. Five adequately vaccinated operators were exposed to a Sabin poliovirus type 3 (PV3) spill. A microbiological risk assessment was conducted and the operators were monitored for PV shedding. On day 5 after exposure, Sabin PV3 was detected only in the stool sample of the most exposed worker. Shedding of Sabin PV3 (as detected by viral culture) was restricted to a very short period (less than 15 days). Monitoring of this incident was an opportunity to assess the relevance of our national response plan. We concluded that the measures undertaken and reported here were appropriate and proportional.https://www.mdpi.com/2076-393X/8/2/331poliovirusincidentaccidentrisk assessmentcontainment breachGAP III
collection DOAJ
language English
format Article
sources DOAJ
author Marion Jeannoël
Denise Antona
Clément Lazarus
Bruno Lina
Isabelle Schuffenecker
spellingShingle Marion Jeannoël
Denise Antona
Clément Lazarus
Bruno Lina
Isabelle Schuffenecker
Risk Assessment and Virological Monitoring Following an Accidental Exposure to Concentrated Sabin Poliovirus Type 3 in France, November 2018
Vaccines
poliovirus
incident
accident
risk assessment
containment breach
GAP III
author_facet Marion Jeannoël
Denise Antona
Clément Lazarus
Bruno Lina
Isabelle Schuffenecker
author_sort Marion Jeannoël
title Risk Assessment and Virological Monitoring Following an Accidental Exposure to Concentrated Sabin Poliovirus Type 3 in France, November 2018
title_short Risk Assessment and Virological Monitoring Following an Accidental Exposure to Concentrated Sabin Poliovirus Type 3 in France, November 2018
title_full Risk Assessment and Virological Monitoring Following an Accidental Exposure to Concentrated Sabin Poliovirus Type 3 in France, November 2018
title_fullStr Risk Assessment and Virological Monitoring Following an Accidental Exposure to Concentrated Sabin Poliovirus Type 3 in France, November 2018
title_full_unstemmed Risk Assessment and Virological Monitoring Following an Accidental Exposure to Concentrated Sabin Poliovirus Type 3 in France, November 2018
title_sort risk assessment and virological monitoring following an accidental exposure to concentrated sabin poliovirus type 3 in france, november 2018
publisher MDPI AG
series Vaccines
issn 2076-393X
publishDate 2020-06-01
description The safe and secure containment of infectious poliovirus (PV) in facilities where live PV are handled is the condition to achieve and maintain poliomyelitis eradication. Despite precautions to minimize the risk of release of PV from such facilities to the environment, breaches of containment have already been documented. Here, we report the management of an incident that occurred on 30 November 2018 in a French vaccine manufacturing plant. Five adequately vaccinated operators were exposed to a Sabin poliovirus type 3 (PV3) spill. A microbiological risk assessment was conducted and the operators were monitored for PV shedding. On day 5 after exposure, Sabin PV3 was detected only in the stool sample of the most exposed worker. Shedding of Sabin PV3 (as detected by viral culture) was restricted to a very short period (less than 15 days). Monitoring of this incident was an opportunity to assess the relevance of our national response plan. We concluded that the measures undertaken and reported here were appropriate and proportional.
topic poliovirus
incident
accident
risk assessment
containment breach
GAP III
url https://www.mdpi.com/2076-393X/8/2/331
work_keys_str_mv AT marionjeannoel riskassessmentandvirologicalmonitoringfollowinganaccidentalexposuretoconcentratedsabinpoliovirustype3infrancenovember2018
AT deniseantona riskassessmentandvirologicalmonitoringfollowinganaccidentalexposuretoconcentratedsabinpoliovirustype3infrancenovember2018
AT clementlazarus riskassessmentandvirologicalmonitoringfollowinganaccidentalexposuretoconcentratedsabinpoliovirustype3infrancenovember2018
AT brunolina riskassessmentandvirologicalmonitoringfollowinganaccidentalexposuretoconcentratedsabinpoliovirustype3infrancenovember2018
AT isabelleschuffenecker riskassessmentandvirologicalmonitoringfollowinganaccidentalexposuretoconcentratedsabinpoliovirustype3infrancenovember2018
_version_ 1724513043300220928